ArticleMolecular cancer therapeutics2023

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.

Joel Morris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.